
Constipation Treatment Market Report and Forecast 2024-2032
Description
Constipation Treatment Market Report and Forecast 2024-2032
Constipation Treatment Market Report and Forecast 2024-2032
Constipation Treatment Market Outlook
The constipation treatment market size was valued at USD 9.1 billion in 2023, driven by development of new diagnostic biomarkers across the major markets. The market size is anticipated to grow at a CAGR of 5.8% during the forecast period of 2024-2032, and likely to attain a value of USD 15.2 billion by 2032.
Constipation: Introduction
Constipation is a common digestive condition characterized by infrequent bowel movements or difficulty passing stools. It often results from a diet low in fiber, inadequate hydration, or lack of physical activity. Symptoms include hard, dry stools, straining during bowel movements, and a feeling of incomplete evacuation. Constipation can also be caused by certain medications or medical conditions. The treatment typically involves lifestyle changes like increased fiber intake, hydration, and exercise, sometimes supplemented by over-the-counter laxatives for temporary relief.
Key Trends in the Constipation Treatment Market
There's an increasing consumer preference towards natural and herbal remedies, driven by concerns over the side effects of conventional laxatives. This includes increased use of fiber supplements, probiotics, and herbal teas.
Pharmaceutical companies are investing in the development of new drugs that are more effective with fewer side effects. This includes medications that work by stimulating bowel movements or softening stool.
The market is seeing a surge in functional foods, like those high in fiber, and probiotics, which are known to aid digestion and alleviate constipation.
There's a growing trend of self-care, with more people seeking over-the-counter solutions for constipation. This is coupled with increased awareness about the importance of digestive health.
Emphasis on lifestyle modifications such as increased physical activity, proper hydration, and dietary changes is becoming more prevalent as a first-line approach to prevent and treat constipation.
Innovative technologies for the diagnosis and monitoring of gastrointestinal issues, including constipation, are on the rise, enhancing personalized treatment approaches.
With an aging global population, there's a growing focus on treating constipation in the elderly, who are more prone to the condition due to various factors like reduced mobility and medication side effects.
Increasing attention is being given to the pediatric segment, with the development of child-friendly, safe, and effective constipation treatments.
Constipation Treatment Market Segmentation
Constipation Treatment Market Segmentation
Market Breakup by Product Type
· Mu-Opioid Receptor Antagonists
· Laxative
· Chloride Channel-2 Activator
· Guanylate Cyclase-C (GC-C) Agonist
· Others
Market Breakup by Disease Type
· Opioid-Induced Constipation
· Chronic Idiopathic Constipation
· Irritable Bowel Syndrome with Constipation
Market Breakup by Prescription Type
· Corticosteroids Prescribed Drugs
· Over-the-Counter Drugs
Market Breakup by Distribution Channel
· Online Pharmacy
· Drug Store and Retail Pharmacy
· Other
Market Breakup by Region
· United States
· EU-4 and the United Kingdom
- Germany
- France
- Italy
- Spain
- United Kingdom
Constipation Treatment Market Overview
In North America, United States and Canada typically exhibit a high adoption rate of newer, prescription medications due to strong healthcare infrastructure and high patient awareness. There is a significant market for over the counter (OTC) laxatives and prescription drugs. Emphasis on lifestyle changes such as diet and exercise are prevalent. There's also a growing trend towards natural and organic remedies.
Similar to North America, there's a high adoption rate of new medications in Western Europe. The region also has strict regulatory standards for the approval of new drugs.
In Asia-Pacific, developed nations such as Japan, Australia, South Korea have advanced healthcare systems, like Western nations, and show openness to both modern and traditional treatments. In India, China, and Southeast Asia, the market is diverse, with a mix of modern healthcare facilities in urban areas and traditional remedies in rural regions.
Constipation Treatment Market: Competitor Landscape
The key features of the market report include patent analysis, grants analysis, clinical trials analysis, funding and investment analysis, partnerships, and collaborations analysis by the leading key players. The major companies in the market are as follows:
- Takeda Pharmaceutical Company Ltd.
- Ironwood Pharmaceuticals, Inc.
- Salix Pharmaceuticals, Inc.
- Abbott Laboratories
- AstraZeneca Plc
- Cosmo Pharmaceuticals NV
- Sanofi S.A.
- Bayer AG
- Valeant Pharmaceuticals International Inc.
- Pfizer Inc
- Synergy Pharmaceuticals, Inc.
- Janssen Pharmaceutical Company
- Boehringer Ingelheim GmbH
- Ardelyx Inc.
- AbbVie Inc.
*Please Note:* The report will take 7 business days to complete, after order confirmation.
Table of Contents
180 Pages
- 1 Preface
- 1.1 Objectives of the Study
- 1.2 Key Assumptions
- 1.3 Report Coverage – Key Segmentation and Scope
- 1.4 Research Methodology
- 2 Executive Summary
- 3 Constipation Treatment Overview
- 3.1 Guidelines and Stages
- 3.2 Pathophysiology
- 3.3 Screening and Diagnosis
- 3.4 Treatment Pathway
- 4 Patient Profile
- 4.1 Patient Profile Overview
- 4.2 Patient Psychology and Emotional Impact Factors
- 4.3 Risk Assessment and Treatment Success Rate
- 5 Constipation Treatment Epidemiology Analysis – Seven Major Markets
- 5.1 7MM Epidemiology Scenario Overview (2017-2032)
- 5.2 United States Constipation Treatment Epidemiology Forecast (2017-2032)
- 5.3 EU-4 and United Kingdom Constipation Treatment Epidemiology Forecast (2017-2032)
- 5.3.1 Germany Constipation Treatment Epidemiology Forecast (2017-2032)
- 5.3.2 France Constipation Treatment Epidemiology Forecast (2017-2032)
- 5.3.3 Italy Constipation Treatment Epidemiology Forecast (2017-2032)
- 5.3.4 Spain Constipation Treatment Epidemiology Forecast (2017-2032)
- 5.3.5 United Kingdom Constipation Treatment Epidemiology Forecast (2017-2032)
- 5.4 Japan Constipation Treatment Epidemiology Forecast (2017-2032)
- 6 Constipation Treatment Market Overview – 7MM
- 6.1 Constipation Treatment Market Historical Value (2017-2023)
- 6.2 Constipation Treatment Market Forecast Value (2024-2032)
- 7 Constipation Treatment Market Landscape – 7MM
- 7.1 Constipation Treatment Developers Landscape
- 7.1.1 Analysis by Year of Establishment
- 7.1.2 Analysis by Company Size
- 7.1.3 Analysis by Region
- 7.2 Constipation Treatment Product Landscape
- 7.2.1 Analysis by Product Type
- 7.2.2 Analysis by Disease Type
- 8 Constipation Treatment Challenges and Unmet Needs
- 8.1 Treatment Pathway Challenges
- 8.2 Compliance and Drop-Out Analysis
- 8.3 Awareness and Prevention Gaps
- 9 Cost of Treatment
- 10 Constipation Treatment Market Dynamics
- 10.1 Market Drivers and Constraints
- 10.2 SWOT Analysis
- 10.3 Porter’s Five Forces Model
- 10.4 Key Demand Indicators
- 10.5 Key Price Indicators
- 10.6 Industry Events, Initiatives, and Trends
- 10.7 Value Chain Analysis
- 11 Constipation Treatment Market Segmentation – 7MM
- 11.1 Constipation Treatment Market by Product Type
- 11.1.1 Market Overview
- 11.1.2 Mu-Opioid Receptor Antagonists
- 11.1.3 Laxative
- 11.1.4 Chloride Channel-2 Activator
- 11.1.5 Guanylate Cyclase-C (GC-C) Agonist
- 11.1.6 Others
- 11.2 Constipation Treatment Market by Disease Type
- 11.2.1 Market Overview
- 11.2.2 Opioid-Induced Constipation
- 11.2.3 Chronic Idiopathic Constipation
- 11.2.4 Irritable Bowel Syndrome with Constipation
- 11.3 Constipation Treatment Market by Prescription Type
- 11.3.1 Market Overview
- 11.3.2 Corticosteroids Prescribed Drugs
- 11.3.3 Over-the-Counter Drugs
- 11.4 Constipation Treatment Market by Distribution Channel
- 11.4.1 Market Overview
- 11.4.2 Online Pharmacy
- 11.4.3 Drug Store and Retail Pharmacy
- 11.4.4 Other
- 11.5 Constipation Treatment Market by Region
- 11.5.1 Market Overview
- 11.5.2 United States
- 11.5.3 EU-4 and the United Kingdom
- 11.5.3.1 Germany
- 11.5.3.2 France
- 11.5.3.3 Italy
- 11.5.3.4 Spain
- 11.5.3.5 United Kingdom
- 11.5.4 Japan
- 12 United States Constipation Treatment Market
- 12.1 Constipation Treatment Market Historical Value (2017-2023)
- 12.2 Constipation Treatment Market Forecast Value (2024-2032)
- 12.2.1 Constipation Treatment Market by Product Type
- 12.2.2 Constipation Treatment Market by Disease Type
- 13 EU-4 and United Kingdom Constipation Treatment Market
- 13.1 Constipation Treatment Market Historical Value (2017-2023)
- 13.2 Constipation Treatment Market Forecast Value (2024-2032)
- 13.3 Germany Constipation Treatment Market Overview
- 13.3.1 Constipation Treatment Market by Product Type
- 13.3.2 Constipation Treatment Market by Disease Type
- 13.4 France Constipation Treatment Market Overview
- 13.4.1 Constipation Treatment Market by Product Type
- 13.4.2 Constipation Treatment Market by Disease Type
- 13.5 Italy Constipation Treatment Market Overview
- 13.5.1 Constipation Treatment Market by Product Type
- 13.5.2 Constipation Treatment Market by Disease Type
- 13.6 Spain Constipation Treatment Market Overview
- 13.6.1 Constipation Treatment Market by Product Type
- 13.6.2 Constipation Treatment Market by Disease Type
- 13.7 United Kingdom Constipation Treatment Market Overview
- 13.7.1 Constipation Treatment Market by Product Type
- 13.7.2 Constipation Treatment Market by Disease Type
- 14 Japan Constipation Treatment Market
- 14.1 Constipation Treatment Market Historical Value (2017-2023)
- 14.2 Constipation Treatment Market Forecast Value (2024-2032)
- 14.2.1 Constipation Treatment Market by Product Type
- 14.2.2 Constipation Treatment Market by Disease Type
- 15 Patent Analysis
- 15.1 Analysis by Type of Patent
- 15.2 Analysis by Publication year
- 15.3 Analysis by Issuing Authority
- 15.4 Analysis by Patent Age
- 15.5 Analysis by CPC Analysis
- 15.6 Analysis by Patent Valuation
- 15.7 Analysis by Key Players
- 16 Grants Analysis
- 16.1 Analysis by year
- 16.2 Analysis by Amount Awarded
- 16.3 Analysis by Issuing Authority
- 16.4 Analysis by Grant Application
- 16.5 Analysis by Funding Institute
- 16.6 Analysis by NIH Departments
- 16.7 Analysis by Recipient Organization
- 17 Clinical Trials Analysis
- 17.1 Analysis by Trial Registration Year
- 17.2 Analysis by Trial Status
- 17.3 Analysis by Trial Phase
- 17.4 Analysis by Therapeutic Area
- 17.5 Analysis by Geography
- 18 Funding and Investment Analysis
- 18.1 Analysis by Funding Instances
- 18.2 Analysis by Type of Funding
- 18.3 Analysis by Funding Amount
- 18.4 Analysis by Leading Players
- 18.5 Analysis by Leading Investors
- 18.6 Analysis by Geography
- 19 Partnership and Collaborations Analysis
- 19.1 Analysis by Partnership Instances
- 19.2 Analysis by Type of Partnership
- 19.3 Analysis by Leading Players
- 19.4 Analysis by Geography
- 20 Supplier Landscape
- 20.1 Takeda Pharmaceutical Company Ltd.
- 20.1.1 Financial Analysis
- 20.1.2 Product Portfolio
- 20.1.3 Demographic Reach and Achievements
- 20.1.4 Mergers and Acquisition
- 20.1.5 Certifications
- 20.2 Ironwood Pharmaceuticals, Inc.
- 20.2.1 Financial Analysis
- 20.2.2 Product Portfolio
- 20.2.3 Demographic Reach and Achievements
- 20.2.4 Mergers and Acquisition
- 20.2.5 Certifications
- 20.3 Salix Pharmaceuticals, Inc.
- 20.3.1 Financial Analysis
- 20.3.2 Product Portfolio
- 20.3.3 Demographic Reach and Achievements
- 20.3.4 Mergers and Acquisition
- 20.3.5 Certifications
- 20.4 Abbott Laboratories
- 20.4.1 Financial Analysis
- 20.4.2 Product Portfolio
- 20.4.3 Demographic Reach and Achievements
- 20.4.4 Mergers and Acquisition
- 20.4.5 Certifications
- 20.5 AstraZeneca Plc
- 20.5.1 Financial Analysis
- 20.5.2 Product Portfolio
- 20.5.3 Demographic Reach and Achievements
- 20.5.4 Mergers and Acquisition
- 20.5.5 Certifications
- 20.6 Cosmo Pharmaceuticals NV
- 20.6.1 Financial Analysis
- 20.6.2 Product Portfolio
- 20.6.3 Demographic Reach and Achievements
- 20.6.4 Mergers and Acquisition
- 20.6.5 Certifications
- 20.7 Sanofi S.A.
- 20.7.1 Financial Analysis
- 20.7.2 Product Portfolio
- 20.7.3 Demographic Reach and Achievements
- 20.7.4 Mergers and Acquisition
- 20.7.5 Certifications
- 20.8 Bayer AG
- 20.8.1 Financial Analysis
- 20.8.2 Product Portfolio
- 20.8.3 Demographic Reach and Achievements
- 20.8.4 Mergers and Acquisition
- 20.8.5 Certifications
- 20.9 Valeant Pharmaceuticals International Inc.
- 20.9.1 Financial Analysis
- 20.9.2 Product Portfolio
- 20.9.3 Demographic Reach and Achievements
- 20.9.4 Mergers and Acquisition
- 20.9.5 Certifications
- 20.10 Pfizer Inc
- 20.10.1 Financial Analysis
- 20.10.2 Product Portfolio
- 20.10.3 Demographic Reach and Achievements
- 20.10.4 Mergers and Acquisition
- 20.10.5 Certifications
- 20.11 Synergy Pharmaceuticals, Inc.
- 20.11.1 Financial Analysis
- 20.11.2 Product Portfolio
- 20.11.3 Demographic Reach and Achievements
- 20.11.4 Mergers and Acquisition
- 20.11.5 Certifications
- 20.12 Janssen Pharmaceutical Company
- 20.12.1 Financial Analysis
- 20.12.2 Product Portfolio
- 20.12.3 Demographic Reach and Achievements
- 20.12.4 Mergers and Acquisition
- 20.12.5 Certifications
- 20.13 Boehringer Ingelheim GmbH
- 20.13.1 Financial Analysis
- 20.13.2 Product Portfolio
- 20.13.3 Demographic Reach and Achievements
- 20.13.4 Mergers and Acquisition
- 20.13.5 Certifications
- 20.14 Ardelyx Inc.
- 20.14.1 Financial Analysis
- 20.14.2 Product Portfolio
- 20.14.3 Demographic Reach and Achievements
- 20.14.4 Mergers and Acquisition
- 20.14.5 Certifications
- 20.15 AbbVie Inc.
- 20.15.1 Financial Analysis
- 20.15.2 Product Portfolio
- 20.15.3 Demographic Reach and Achievements
- 20.15.4 Mergers and Acquisition
- 20.15.5 Certifications
- 21 Key Opinion Leaders (KOL) Insights (Additional Insight)
- 22 Company Competitiveness Analysis (Additional Insight)
- 22.1 Very Small Companies
- 22.2 Small Companies
- 22.3 Mid-Sized Companies
- 22.4 Large Companies
- 22.5 Very Large Companies
- 23 Payment Methods (Additional Insight)
- 23.1 Government Funded
- 23.2 Private Insurance
- 23.3 Out-of-Pocket
- *Additional insights provided are customisable as per client requirements.
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.